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Abstract
Purpose—Tobacco and alcohol use are well-known risk factors for squamous cell carcinoma of
the head and neck (SCCHN), but there has been little examination of disparities in SCCHN and
racial patterns of tobacco and alcohol use, especially for African-Americans. The Carolina Head
and Neck Cancer Study, a population-based case-control study, was utilized to determine if
relationships between tobacco and alcohol use and SCCHN differed by race.
Methods—Using a rapid case ascertainment system, cases were recruited from 46 contiguous
counties in North Carolina from 2002–2006. Controls, selected from motor vehicle records, were
frequency-matched to cases on age, sex, and race. This analysis was based on 989 white and 351
African-American cases and 1114 white and 264 African-American controls. Analyses were
performed using unconditional logistic regression, adjusting for age, sex, race, education and fruit
and vegetable consumption.
Results—The association between SCCHN and ever tobacco use among African-Americans
(odds ratio (OR) 9.68 95% confidence interval (CI) 4.70, 19.9) was much greater than that
observed in whites (OR:1.94 95% CI 1.51, 2.50). Smaller differences were observed when
examining ever alcohol use (African-Americans OR: 3.71 CI 1.65, 8.30 Whites OR: 1.31 CI 0.96,
1.78). African-Americans consistently had greater effect measure estimates when examining
common levels of duration and intensity metrics of tobacco and alcohol use, both independently
and jointly. No racial differences in the effects of environmental (passive) tobacco smoke were
observed.
Conclusions—These findings suggest racial differences in SCCHN are not solely explained by
differences in consumption patterns, and tobacco and alcohol may have greater impact in African-
Americans.
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Squamous cell carcinoma of the head and neck (SCCHN) is one of the ten most frequently
diagnosed cancers globally and consists of cancers found in the oral cavity, pharynx and
larynx [1]. Within the United States, the American Cancer Society estimates that there will
be 52,140 new cases and 11,460 deaths attributable to these cancers in 2011 [2]. Data from
the National Cancer Institute’s Surveillance Epidemiology and End Results database
(SEER) suggest racial disparities in incidence and mortality related to these cancers, with
African-American males bearing the largest burden of disease [3]. These disparities are
especially pronounced for laryngeal cancer. From 1975–2008, the age-adjusted incidence
rate for laryngeal cancer among African-American males was 12.8 per 100,000, compared to
8.0 in White males, 2.5 in Black females, and 1.6 in White females [4]. African-American
males also have the greatest rate of oropharyngeal cancer, 21.8 per 100,000 compared to
17.9 for White males, 7.1 for White females and 7.0 for African-American females,
although in recent years the rate among White males has been increasing [4]. In North
Carolina, the 2005–2009 age-adjusted incidence rate for SCCHN was 10.2 per 100,000
among whites and 12.4 per 100,000 among African-Americans. There are also disparity in
mortality in North Carolina with an age-adjusted mortality rate per 100,000 people of 3.0
among whites and 5.6 among African-Americans [5].
Tobacco use and alcohol consumption have been consistently demonstrated to be risk
factors for SCCHN in U.S. and international epidemiologic studies [6]. Findings document
clear dose-response relationships and evidence of interaction between tobacco and alcohol
use in contributing to SCCHN risk [7, 8]. Previous research estimated that use of tobacco
and/or alcohol may account for three-fourths of all oral and pharyngeal cancers in the United
States. [7] Since then, research suggests that infection with human papillomavirus (HPV)
may also contribute to certain subtypes of SCCHN, particularly among non-smokers and
non-drinkers [9, 10].
Despite the evidence that SCCHN incidence varies by race and, overall, may be largely
attributable to tobacco and alcohol use, there has been little focus on differences in
consumption patterns between ethnic and racial groups, especially for African-Americans.
Using data from a case-control study conducted between 1984 and1985, Day et al conducted
one of the few comparisons of risk factors between African-Americans and whites and
found slightly different consumption patterns by race [11]. Their findings, based on 194
African-American cases, showed similar odds of oral and pharyngeal cancer associated with
tobacco use between the groups but noted some differences in the relationship between
alcohol consumption and oral cancer, with African-Americans having greater odds of
disease. Laryngeal cancer was not included in their study case group.
The objective of the present analysis was to utilize a large population-based case-control
study of oral, pharyngeal and laryngeal cancers, in order to determine if the relationships
between tobacco and alcohol use and risk of SCCHN were different for African-Americans
and whites. This analysis included examination of the interaction between tobacco and
alcohol use and stratification by different sites of SCCHN.
Materials and Methods
The Carolina Head and Neck Cancer Study (CHANCE) included cases, aged 20–80, who
were residents of a 46-county region in North Carolina with newly diagnosed first primary
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invasive SCCHN between January 1, 2002 and February 28, 2006 [12]. We included ICD-
O-3 topography codes C01.9 to C14.8 and C32.0 to C32.9. We excluded tumors of the lip
(C0.00–C00.9), salivary glands (C07.9, C08.0–C08.9), nasopharynx (C11.0–C11.9), nasal
cavity (C30.0), and nasal sinuses (C31.0–C31.9). Subjects with carcinomas of other
histologies, carcinomas at other head and neck sites, or a history of recurrent or second
primary tumors were not eligible. Using rapid case ascertainment conducted through the
North Carolina Central Cancer Registry, cancer registrars at the 54 hospitals in the study
were contacted monthly to identify and provide eligible, newly diagnosed cases. Pathology
reports and corresponding slides of tumor specimens from the patient’s diagnostic surgery
were obtained, usually within 4–8 weeks of diagnosis, and histologic confirmation was
verified by our study pathologist (WF).
Controls, aged 20 to 80 years, were residents of the same 46 North Carolina counties and
had never been diagnosed with SCCHN. Identified through North Carolina Department of
Motor Vehicle records, controls were frequency matched with cases using random sampling
with stratification on age (20–49,50–54,55–59,60–64,65–69,70–74,75–80), race (white,
black, other), and sex (male, female).
Potentially eligible controls and cases (after physician notification) were first contacted by
mail and then by nurse-interviewers to verify eligibility and schedule an interview. Written
informed consent was obtained prior to the interview, and participants received
compensation for time spent completing the study interview and donating a biologic sample.
For subjects who were deceased, an attempt was made to locate a family member or proxy
with knowledge of the subject’s exposures who was willing to complete an abridged version
of the survey. All study protocols were reviewed and approved by the University of North
Carolina’s Institutional Review Board.
Demographics and exposure to potential SCCHN risk factors and covariates were assessed
during the in-person interview using standardized survey questions. Each potential risk
factor was assessed in a separate section including a gateway question with ever-use defined
as: smoking 100 cigarettes over a lifetime; smoking 20 cigars; use of a pipe at least 20 times;
use of chewing tobacco at least 20 times; use of snuff at least 20 times; drinking 50 beers
over a lifetime; drinking wine 20 times; and drinking hard liquor 20 times. A positive
response to the gateway question triggered additional questions on age started, age stopped
use if quit, years of use, type of cigarette or size of typical alcoholic drink and typical
amount used/consumed. Cases were asked about use the year prior to diagnosis while
controls were asked about current use. Environmental (second hand, passive, involuntary)
tobacco smoke (ETS) exposure was determined by asking if participants had been exposed
to tobacco smoke at work or home and the number of cigarettes, cigars, or pipefulls that
each person in the household smoked inside the home.
Using responses to these questions and based on the distribution, cigarette and alcohol use
were classified by intensity, duration, and cumulative use. The number of cigarettes smoked
per day was categorized into the following: never-smoker, less than 19 cigarettes per day,
and 20 or more cigarettes per day. Duration was defined in years using the categories of
never smoker, 1–19, 20–39, 40–49 and 50 or more. Cumulative use was defined by pack-
years, calculated by multiplying the number of cigarette packs (20 cigarettes per pack)
smoked per day by the total number of years smoked and then categorized into never-
smokers, less than 20 pack-years, and 20 or more.
Beer, liquor and wine consumption were each coded as six-level variables with the
following categories: 0, <1, 1–4, 5–14, 15–29, and 30 or more drinks per week. Duration of
consumption of each of these beverages was coded as: never, 1–9 years, 10–19 years, and 20
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or more years. Cumulative alcohol use was calculated by converting the number of each
type of drink consumed per week to total ethanol grams then multiplying by years that type
of alcohol was consumed, and then summing across the three types of alcohol.
Subsequently, the cumulative, or total, alcohol variable was categorized into a 5-level
variable, with a never drinker category and four categories defined by quartiles of
consumption among all participants to prevent the undue influence of extreme values.
The odds ratio (OR) estimate for the effect of each exposure on SCCHN was obtained using
unconditional logistic regression, with the matching factors and their interactions included
within each model. Based on review of the literature, all models were a priori adjusted for
education, classified as high school or less, some college, and college degree or more, and
quintiles of fruit and vegetable consumption [13]. Fruit and vegetable consumption were
separately calculated based on reported dietary intake [13]. Proxy respondents were
excluded from multivariable analysis because they lacked data on fruit and vegetable
consumption. Models with cigarette exposure variables as the main exposure also adjusted
for alcohol consumption, using the categorical variable of total ethanol consumed, and use
of other tobacco products. Models examining other tobacco use variables adjusted for
alcohol consumption and duration of cigarette smoking. Models focusing on alcohol use
variables also adjusted for duration of cigarette smoking and use of other tobacco products.
To examine differences in risk factors for SCCHN between African-Americans and whites,
we included an interaction term between the exposure and race and conducted likelihood
ratio tests, specifying an alpha level of 0.10. Models were also stratified by cancer site, using
the following definitions: oral cavity (ICD-O-3 C01.9–C02.3, C03.0–C03.1, C03.9, C04.0–
C04.4, C04.8–C05.0, C06.0–C06.2, C06.8–C06.9), oropharynx (C02.4, C05.1–C05.2,
C09.0–C09.1, C09.8–C10.4, C10.8–C10.9), hypopharynx (C12.9–C13.2, C13.8–C13.9),
oral cavity-oropharynx-hypopharynx not otherwise specified (C02.8–C02.9, C05.8–C05.9,
C014.0), or larynx (C32.0–C32.9). Additional analyses were stratified by cancer sites that
are known to be related to HPV infection (C01.9-base of tongue, NOS, C02.4-lingual tonsil,
C09.0–C09.9-tonsil, C10.0–C10.9-oropharynx) [10], as it is hypothesized that tobacco and
alcohol would play less of a role in the etiology of these cancers. When examining the data
by site, some exposure categories were collapsed due to smaller sample size.
In order to examine joint effects of tobacco and alcohol exposure, we constructed an
unconditional logistic regression model which included interaction terms between duration
of cigarette smoking and weekly alcohol consumption, defined as total number of drinks per
week. We chose these two measures of tobacco and alcohol consumption in order to explore
the combination of the most definitive metrics representing the highest risk behaviors
identified in earlier analyses. Due to small sample size, we combined the never drinkers and
very light drinkers (< 1 drink per week) into a single category. To explore interaction on the
additive scale, interaction contrast ratios (ICRs) and 95% confidence intervals were
calculated comparing those who used the greatest amounts of both tobacco and alcohol to
those with no tobacco and alcohol use [14]. All analyses were performed using SASv9.2.
Results
Case response proportions were similar between African-Americans and whites, 74.9% and
77.0%. Control response rates were 35.8% among African-Americans and 51.4% for whites.
This difference is driven in part by the lower contact rate for African-American controls
(62.7% versus 82.8% for whites). Overall, the questionnaire was completed for 1,389
eligible cases and 1,396 eligible controls. Twenty-one cases of lip cancer were excluded, as
were 28 cases and 18 controls who specified ‘other race’. The final sample consisted of
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1340 cases (989 white, 351 African-American) and 1378 controls (1114 white, 264 African-
American). Only 51 cases (3.8%) and 17 controls (1.2%) required proxy interviews.
Table 1 presents case and control distributions for demographic factors, stratified by race.
Both races had greater educational attainment among controls. Although there were
univariate differences between cases and controls for the matching factors age, race and sex,
comparison of the joint distribution of these variables between cases and controls showed
less than a 2.0% difference for all combinations (data not shown).
The association between SCCHN and ever tobacco use among African-Americans (OR:
9.68 95% confidence interval (CI) 4.70, 19.9) was much greater than that observed in whites
(OR:1.94 95% CI 1.51, 2.50). As shown in Table 2, the odds ratios for measures of cigarette
smoking intensity and duration are larger in magnitude for African-Americans than whites,
although the estimates for African-Americans are less precise. Among those at the higher
levels of duration and cigarettes per day of cigarette use, African-Americans had a 6–9-fold
greater odds of SCCHN than among whites. Likelihood ratio tests indicated these
differences are statistically significant, and suggest that race modifies the relationship
between various measures of cigarette use and the effect on SCCHN incidence. We
examined finer categorizations of cigarettes per day and found the racial differences in odds
of cancer remained. Among African Americans, odds ratios for 1–19, 20–39, 40–59, and
60+ cigarettes per day, compared to referent never smokers were 6.42 (3.01, 13.7), 12.6
(5.81,27.1), 59.6 (15.0, 237), and 14.8 (3.01, 72.9), respectively. Among whites, these odds
ratios were 1.15 (0.83, 1.59), 2.38 (1.80, 3.15), 3.06 (2.14, 4.38), and 2.23 (1.16, 4.27),
respectively. Because the effect estimates for categories over 20 cigarettes per day were very
imprecise with wide confidence intervals among African-Americans, we decided to collapse
them into a single 20+ category. We also examined pack-years smoked and found similar
results, with African-Americans consistently having higher odds ratios than whites (data not
shown).
SCCHN risk decreased as the number of years since quitting increased for both races, but
the odds ratios remained greater, but more imprecise, among African-Americans. There was
also a stronger relationship between initiating cigarette use at a younger age and SCCHN
among African-Americans than whites. When examining type of cigarette smoked, there
was a greater variability in odds of disease among African-Americans. However, these
estimates were imprecise.
Subsequently, we restricted our analyses to only smokers and further examined the effects of
smoking frequency and duration using continuous measures of the smoking metrics. For
every 10 year increase in smoking duration, the odds of SCCHN doubled among African-
American smokers (OR: 2.03 95% CI 1.61., 2.55), compared to an increase of 1.46 times the
odds among white smokers (95%CI 1.33, 1.60). For every 10 pack-year increase in cigarette
smoking, the odds of SCCHN were 1.43 (95% CI 1.26, 1.61) times greater when examining
African-American smokers and 1.20 (1.14, 1.25) times greater among white smokers.
Similar results were observed when examining the effect of an increase of 10 cigarettes
smoked per day [(African-Americans OR: 1.56 (95% CI 1.26, 1.93) vs whites OR: 1.25
(95% CI 1.14, 1.37)].
When we examined the individual effects of other types of tobacco, simultaneously
controlling for the others as well as cigarette use, we did not observe any strong
relationships with the odds of SCCHN (Table 2). After stratifying by race, we observed
elevated, though imprecise, ORs among African-Americans when examining the
relationship between use of either snuff or chew and SCCHN, and the likelihood ratio test
examining the interaction between race and snuff use was statistically significant using our
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criteria of 0.10. In order to differentiate the effects of other types of tobacco from each other
as well as from cigarette use, we created a variable which separates use of a single form of
tobacco from using multiple types. As seen in Table 2, those who smoked cigars and/or
pipes only also have elevated odds of SCCHN. The odds of SCCHN associated with the use
of multiple types of smokeable tobacco was not greater than using cigarettes alone. The
small number of cases who used smokeless tobacco alone made interpretation difficult due
to poor precision, but African-Americans who used only smokeless tobacco had a slightly
elevated odds of SCCHN.
In order to detangle the effects of active tobacco use from ETS, we stratified the ETS
models by ever use of tobacco products (Table 3). Among never users of tobacco, odds ratio
estimates for different measures of ETS exposure were less than 1. Among self-tobacco
users, exposure to ETS was associated with SCCHN, and the odds ratios trended higher as
the amount of ETS exposure increased. This relationship is seen in both African-Americans
and whites.
For alcohol consumption, there were racial differences in the magnitude of associations with
SCCHN, although these differences were smaller than those observed for cigarette use. The
odds ratio corresponding to any lifetime alcohol use among African-Americans (OR 3.71
95% CI 1.65, 8.30) was almost triple that observed among whites (OR 1.31 95% CI 0.96,
1.78). Both races showed greater odds of disease as either amount or duration of alcohol
consumption increased, with African-Americans consistently having slightly larger odds
ratio estimates (Table 4). Using the total alcohol variable, among both racial groups, we
observed that the lowest levels of consumption were associated with decreased odds of
SCCHN, while the highest levels of consumption were associated with greater odds of
SCCHN. Odds ratios related to wine consumption were lower than beer or liquor
consumption, particularly among whites, where ever wine consumption was associated with
reduced odds of SCCHN compared to non-drinkers and only the highest level of wine
consumption (more than 30 drinks per week) was associated with greater odds of SCCHN.
Compared to non-drinkers/very light drinkers and non-smokers, the joint effect of alcohol
and tobacco increased as amount increased, especially for African-Americans (Table 5).
Some of these estimates were very imprecise due to the small numbers within cells. For the
assessment of the additive interaction of consuming the greatest amounts of alcohol and
tobacco compared to non-users, the overall ICR was 10.3 (95% CI 3.81,16.8), suggesting
excess risk due to the interaction between tobacco and alcohol. When stratifying by race, the
ICR for whites was 5.98 (95% CI −0.08, 12.0) and 138 (95% CI −141, 418) for African-
Americans. Among Whites, the odds ratio comparing the highest alcohol users to non/very
light drinkers among non-smokers is similar to the odds ratio comparing the highest users of
tobacco to non-smokers among non/very light drinkers (Table 5). Among African-
Americans, however, the odds ratios suggest that alcohol consumption has less of an effect
on non-smokers than smoking has among non/very light drinkers.
Stratifying by site of primary tumor showed that the relationship between tobacco use and
cancer was consistently greatest for laryngeal tumors and wine consumption was associated
with reduced odds of SCCHN among oral cavity and laryngeal cases (Online Resource 1,
Supplementary Table 1). African-Americans and whites had similar tumor site distributions,
although hypopharynx tumors made up approximately 8% of African-American cases,
compared to only 4% among white cases. When stratifying by both race and site, African-
Americans continued to have greater effect measure estimates related to smoking and
alcohol use than whites for all tumor sites except hypopharynx tumors. However, these
stratified results are based on very small numbers and are highly imprecise. (Online
Resource 1, Supplementary Tables 2 and 3) Whites were slightly more likely to have a
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tumor site with presumed HPV-infection than African-Americans (26.5% vs. 21.6%). The
association between tobacco use and SCCHN was consistently greater among those whose
tumor site was not associated with presumed HPV-infection (Online Resource 1,
Supplementary Table 4). The same was true for beer consumption, but not for wine and
liquor consumption. When examining these results stratified by race, African-Americans
with HPV-related tumor sites have greater odds of SCCHN corresponding to tobacco and
alcohol use compared to those with non-HPV-related sites, although these estimates were
highly imprecise. Wine-consumption was again associated with reduced odds of SCCHN
among whites with non-HPV related tumor sites (Online Resource 1, Supplementary Tables
5 and 6).
We ran additional models which adjusted for each type of alcohol separately, as opposed to
the total consumption variable, as well as models which adjusted for tobacco using pack-
years and found no material difference in the estimates obtained (data not shown). We also
ran joint models using pack-years instead of year of smoking and found similar results (data
not shown). To determine if the racial disparities observed were due to residual confounding
related to education, we reran our analyses using a finer adjustment variable that included 7
levels of education (less than 8 years, 8–11 years, completed high school, vocational work,
some college, college graduate and postgraduate). This finder educational adjustment did not
have a material effect on our results and the racial disparities in the effects of tobacco and
alcohol use remained. No difference in results were found when using conditional logistic
regression models to account for matching. Appropriate model fit was explored and verified
by examining model residuals and delta-betas.
Discussion
This study found the effects of tobacco use and alcohol consumption on odds of SCCHN
were consistently greater among African-Americans, whether measuring exposure by
intensity, duration, or cumulative use. Additionally, the joint effect of tobacco and alcohol
use, as well as the impact of smoking among non-drinkers and the impact of greater
smoking frequency and duration among smokers was greater among African-Americans.
These findings suggest that previously observed racial differences in SCCHN incidence are
not solely explained by differences in consumption patterns between African-Americans and
whites, and the impact of tobacco and alcohol may be stronger in African-Americans.
Our estimates of SCCHN related to tobacco and alcohol use among whites are consistent
with reports from the International Head and Neck Cancer Epidemiology Consortium
(INHANCE), a pooled analysis of 15 case-control studies [8, 15–17]. For example, their
odds ratio comparing those who consumed more than 30 drinks of beer per week to non-
drinkers of 3.2 (2.2, 4.7) was just slightly higher than our result of 2.85 (1.96, 4.16) [15].
Both studies found the relationship between tobacco and SCCHN strongest among laryngeal
cases, with increasing odds of cancer as metrics of smoking duration increased [17]. Our
findings of strong interaction between tobacco and alcohol in contributing to the odds of
SCCHN and a lack of an association when examining ever ETS exposure among never
tobacco users are also consistent with INHANCE analyses. [8, 16]. The reduced risk of
SCCHN with wine consumption, among whites observed in our study was not seen in the
INHANCE analysis but has been observed in other case-control studies of SCCHN [11].
Our results were not entirely consistent with the previous study of differences between
whites and blacks in risk factors for oropharyngeal carcinoma [11]. Although we found
similar racial differences in the relationship between alcohol use and SCCHN, Day et al did
not find any difference in the race-stratified odds ratios corresponding to any cigarette use.
Day et al did not include laryngeal cases in their analysis, and our results showed that the
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relationship between tobacco use and SCCHN was strongest in laryngeal cases [11].
However, we continued to observe racial differences in odds ratios when we restricted to
only oral or oropharyngeal tumor sites, although the estimates were imprecise due to small
numbers. It is possible that, because the previous study was conducted in the mid-1980s,
changing tobacco consumption patterns may explain the differences in our results.
It has been suggested that racial disparities in tobacco-related cancers may be due to the
greater use of mentholated cigarettes among African-Americans [18]. Previous research in
both oropharyngeal and lung cancers have found no excess cancer risk among smokers of
mentholated cigarettes compared to nonmentholated cigarette smokers [18–20]. In our
study, we found that smokers of both unfiltered and filtered menthol cigarettes had the
greatest odds of cancer, although these effect estimates were imprecise. When we focused
on those who smoke filtered cigarettes only, our results among whites show there is little
difference in the odds of SCCHN when comparing those who smoked menthol cigarettes
with those who smoked non-menthol cigarettes. Among African-Americans, smokers of
filtered menthol cigarettes have lower odds than those who smoked filtered non-menthol
cigarettes, similar to a recent study of lung cancer by Blot et al, which also observed lower
odds of cancer among menthol cigarette smokers, among both African-Americans and
whites [20]. It is unclear if mentholation itself or smoking behaviors and other
characteristics of smokers who choose mentholated cigarettes contribute to these findings.
Day et al did not examine other forms of tobacco use, but we observed racial differences in
the relationship between smokeless tobacco and SCCHN. A review by Boffetta et al.
examined 11 studies in the US and Europe and found an increased risk of oral cancer
associated with smokeless tobacco among US-based studies (summary relative risk (RR),
95% CI: 2.6 1.3, 5.2) but not among those conducted in Europe (summary RR, 95% CI 1.0
0.7, 1.3) [21]. Among the US studies, there was evidence of heterogeneity, with two studies
observing null results and larger effect estimates observed in studies of women only. We did
not find strong associations between smokeless tobacco and SCCHN overall, but we did
observe a greater association for snuff use when we restricted to only oral cavity sites (OR,
95% CI: 0.99 (0.61, 1.60) to 1.31 (0.48, 3.61), all sites vs. oral cavity only). Only one of the
previous studies stratified by race and found greater odds of disease among white women
who reported using dry snuff [22]. It was noted that the snuff used by these women had very
high nitrosamine concentrations. It is possible that racial differences in the type of snuff
used, as well as usage patterns, may contribute to the differences observed in our study.
Our findings that African-Americans had a greater odds of SCCHN associated with total
alcohol consumption were consistent with the previous study of racial disparities in
oropharyngeal cancer, but we obtained slightly different results when examining the effects
of consumption frequency for the different types of alcohol. In Day et al, whites had greater
odds ratios related to frequency of beer consumption than African-Americans, while
African-Americans had greater odds ratios related to wine and hard liquor consumption. In
our study, African-Americans had greater effects across all three types of alcohol. In
general, the odds ratios related to alcohol consumption for African-Americans tended to be
higher in our study. The odds ratios amongst whites tended to be higher in the previous
study, especially at the higher levels of consumption. For example, in our study whites who
consumed 30 or more servings of beer per week had an odds ratio of 2.5 (95%CI 1.64, 3.81)
while Day et al observed an odds ratio of 6.2 (95% CI 3.9, 9.9) [11]. These differences could
be partly due to the use of a different referent group in the two studies (combination of light
and non-drinkers vs non-drinkers in the Day study) or the inclusion of laryngeal cases in our
study. Additionally, changes in the ethanol content of the average beer consumed over the
last two decades could also contribute to the differences observed in our study. For example,
light beers, with lower ethanol contents, have increased their market share steadily since the
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late 80s [23]. Because neither study incorporated type of beer or specific alcohol contents
into the analysis, it is possible that a 12oz serving of beer, the metric of beer consumption
used, represents slightly different ethanol amounts, causing differences in the observed odds
of SCCHN.
Although we explored finer adjustments of education in our analysis, residual confounding
related to unmeasured socioeconomic factors is one potential explanation for our findings, as
previous research suggests associations between cancer incidence and socioeconomic status
can vary by race [24, 25]. Recent research suggests that African-Americans and Whites may
smoke cigarettes differently, with African-Americans smoking lower numbers of cigarettes
per day more intensely, leading to higher values of biomarkers of exposure to nicotine and
potential differences in carcinogen exposure given the same reported consumption of
cigarettes [26].
Similarly, previous research has shown that African-Americans and whites consume
different types of alcohol, which could explain some of the differences observed in their
odds of SCCHN. Rothman et al reported that the risk of hypopharyngeal cancer was higher
in those who consumed dark liquors when compared to light liquors, while the risk of
laryngeal cancer was relatively similar [27]. Dark liquors, like cognacs, whiskeys, and dark
rums, contain higher levels of non-alcoholic chemicals that could be potential carcinogens
[27]. While Day et al observed that African-Americans were more likely to drink dark
liquor, they did not see any difference in the odds of SCCHN related to different types of
liquor [11]. There has been research which observed differences in cancer risk when
examining consumption of red versus white wine [28, 29], although other studies have
observed no difference [30]. It is plausible that differences in the specific types of alcoholic
beverages consumed could contribute to the differences observed in our study.
It is also possible that racial differences in tobacco and alcohol metabolism could explain
our results. Previous work among healthy smokers found that African-Americans had a
lower ratio of urinary detoxification by-products to metabolites of the tobacco-related
carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), compared to whites.
This ratio is thought to be a measure of tobacco detoxification capacity. [31]. Additionally, a
number of studies, with mixed results, have examined the relationship between SCCHN and
polymorphisms in genes which code for the metabolic enzymes which are involved in either
the activation or detoxification of chemicals found in tobacco and/or alcohol, although there
has been limited research in African-American populations [ 32, 33]. A meta-analysis by
Varela-Lema et al found an association between one of these polymorphisms, GSTM1-
deletion, and oral cancer only among African-Americans and other populations of African
descent, suggesting the potential for gene-gene or gene-environment interactions to explain
racial disparities in cancer incidence [34].
Previous research suggests that although men are more likely to have SCCHN, than women,
the relationship between tobacco and SCCHN is stronger in women [35]. It is possible that
gender differences between the racial groups being compared could cause differences in the
observed odds ratios. However, there were similar percentages of women in both the
African-American and White groups, and we matched on and adjusted for sex in our study.
Additionally, we conducted a sex- and race-stratified analysis and found that racial
differences persisted although effect measure estimates were higher, but highly imprecise
due to small numbers of women, consistent with previous research. For example, odds ratios
for smoking more than 20 cigarettes per day were 2.05 (1.49, 2.82) and 4.63 (3.00, 7.15) in
white and African-American men respectively, but 10.7 (4.99, 22.7) and 24.0 (10.6, 54.6) in
white and African-American women respectively.
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Our study is among the largest individual population-based studies of head and neck cancer
conducted in the United States. We were able to collect and examine detailed information
about intensity and duration of tobacco and alcohol use in both African-Americans and
whites, enabling us to determine how the independent and joint effects of these factors may
differentially impact racial groups. We had a large enough sample size to examine the
relationship between tobacco and alcohol with different tumor sites, and the population-
based design gives us confidence that our results are generalizable to the underlying
population.
Although we have a larger number of African-Americans in our sample than previous
studies, the still relatively small number led to imprecise estimates when examining certain
exposures. We did not have molecular confirmation of HPV-related cases. Our classification
relied on previous research which identified sites shown to be associated with HPV infection
[10]. Despite this potential for misclassification, our tobacco-related findings among whites
were relatively consistent with previous studies which utilized serology to identify HPV-
related cases, although we did not observe differences in SCCHN and alcohol use
associations by HPV-status similar to previous studies [36, 37]. Our response among
controls was low at 48%, and varied by race with African-American controls having a lower
response. While we do not have data on persons who refused participation, our overall
findings regarding tobacco and alcohol as risk factors for SCCHN are consistent with the
literature, supporting the validity of our study. Comparing our controls to results from the
2002–2005 Behavioral Risk Factor Surveillance System (BRFSS) surveys in North Carolina
suggests that the controls were more likely to ever smoke than the general adult population
of North Carolina within the relevant age range, although our controls were more likely to
be male which could explain part of this discrepancy [38]. This control selection could have
caused our estimates to be lower in magnitude, but would not likely explain the large
differences observed between African-Americans and Whites as both races had greater
prevalence of smoking than their BRFSS counterparts. While recall bias is a limitation
inherent to the case-control design, there is no evidence to suggest that recall of tobacco and
alcohol use varies by race.
In summary, our study found that the relationships between tobacco, alcohol and SCCHN
vary by race, with these risk factors having a greater impact on African-Americans. These
differences may be explained by differences in metabolism, use and cessation patterns and/
or socioeconomic factors that are not fully accounted for in our study. Future studies should
continue to examine racial differences in patterns and metabolism of tobacco and alcohol in
order to understand the racial disparities in SCCHN observed in the United States.
Supplementary Material
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